INS and obesity disorder: These phenomena were not due to obesity because we observed no significant difference in body weight between control mice and mice after daily oral administration of 3 mg/kg/day olanzapine for 5 or 6 weeks (data not shown), but rather due to olanzapine-induced misfolding of proinsulin in pancreatic β cells.